Charles E. Alpers

44.2k citations
389 papers · 25.2k · 7 hit papers · h-index 86

Impact in

  • Nephrology top 0.01%
    • Renal Diseases and Glomerulopathies
    • Chronic Kidney Disease and Diabetes
    • Renal Transplantation Outcomes and Treatments

Papers in

    • Renal Diseases and Glomerulopathies 150
    • Chronic Kidney Disease and Diabetes 63
    • Amyloidosis: Diagnosis, Treatment, Outcomes 35
    • Renal and related cancers 24

Charles E. Alpers

387 papers receiving 24.7k citations

Charles E. Alpers's Hit Papers

Molecular mechanisms and therapeutic targets for diabetic kidney disease 2022 · 349 citations
3490+11+22Years since publication2505007501000

Peers

Charles E. Alpers
Comparison fields: 5 of 159
  • Nephrology 9.2k
  • Transplantation 1.2k
  • Immunology and Allergy 1.7k
  • Immunology 4.5k
  • Rheumatology 3.1k
Replace Vivette D. D’Agati with:
Vivette D. D’Agati United States
Hui Y. Lan Hong Kong
Eric G. Neilson United States
Jeffrey B. Kopp United States
Giovanni Camussi Italy
Wayne A. Border United States
Hans‐Joachim Anders Germany
Kerstin Amann Germany
Robert B. Colvin United States
Paola Romagnani Italy
Charles E. Alpers relative to Vivette D. D’Agati United States Vivette D. D’Agati's profile →
Citations per field
00.5×3.1×
Vivette D. D’Agati · 1×
Citations per year

Countries citing papers authored by Charles E. Alpers

Since Specialization
Citations

This map shows the geographic impact of Charles E. Alpers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Alpers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Alpers more than expected).

Fields of papers citing papers by Charles E. Alpers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Alpers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Alpers. The network helps show where Charles E. Alpers may publish in the future.

Co-authors

The 25 scholars most cited alongside Charles E. Alpers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles E. Alpers Line = papers co-authored together Charles E. Alpers links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 389 papers — load more, or switch the sort, to bring in the rest.

#Work
1
VEGF Inhibition and Renal Thrombotic Microangiopathy
Hit paper breakdown →
20081116
2
Mouse Models of Diabetic Nephropathy
Hit paper breakdown →
2009680
3
Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
Hit paper breakdown →
1993660
4
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
Hit paper breakdown →
2018595
5
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques.
Hit paper breakdown →
1993558
6 1996477
7
Renal injury from angiotensin II-mediated hypertension.
Hit paper breakdown →
1992469
8 1991416
9 1996408
10 1992357
11
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Hit paper breakdown →
2022349
12 1995347
13 1995312
14 1992308
15 1993294
16 1995283
17 1991264
18 1999259
19 1996248
20 1991245

About Charles E. Alpers

Charles E. Alpers is a scholar working on Nephrology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 389 papers that have together received 25.2k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (150 papers), Chronic Kidney Disease and Diabetes (63 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (35 papers), Complement system in diseases (31 papers), Systemic Lupus Erythematosus Research (30 papers), Renal and related cancers (24 papers), Cell Adhesion Molecules Research (24 papers) and Renal Transplantation Outcomes and Treatments (20 papers). The work is most often cited by research in Nephrology (9.2k citations), Transplantation (1.2k citations), Immunology and Allergy (1.7k citations), Immunology (4.5k citations) and Rheumatology (3.1k citations). Charles E. Alpers has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Kelly L. Hudkins, Richard J. Johnson, William G. Couser, Kevin D. O’Brien, Jürgen Floege, P Pritzl, Agnes B. Fogo, Katherine Gordon, Cecilia M. Giachelli and Stuart J. Shankland. Their work appears in journals such as American Journal of Kidney Diseases, Kidney International, Journal of the American Society of Nephrology, American Journal of Physiology-Renal Physiology and Current Opinion in Nephrology & Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact